Australia and New Zealand Joint Therapeutic Products Regulator Canned
Plans to establish a joint therapeutic products regulator between Australia and New Zealand have ceased.
The announcement was made by the Hon Peter Dutton MP, Minister for Health for Australia, and the Hon Dr Jonathan Coleman, Minister of Health for New Zealand following a comprehensive review of progress and assessment of the costs and benefits to each country.
While work on ANZTPA will cease, Australia and New Zealand will continue to co-operate on the regulation of therapeutic products where there are mutual benefits for consumers, businesses and regulators in each country.
In a statement, Mr Dutton says Australia’s Therapeutic Goods Administration (TGA) and New Zealand’s Medicines and Medical Devices Safety Authority (Medsafe) will continue to explore other trans-Tasman regulatory harmonisation activities that represent potential value to both countries, and that build upon earlier business-to-business projects.
"These include the development of a new information sharing agreement and formalising mutual recognition of good manufacturing practice audits. This work will increase the potential for regulatory alignment over time to reduce compliance costs, Mr Dutton says.
"Each country will now proceed with its own domestic therapeutics regulatory reform program but we remain open to future cooperation activities. Ministers will continue their bilateral engagement, including through New Zealand’s participation in the Council of Australian Governments (COAG) Health Council."
The new facility, accredited by the National Association of Testing Authorities, has the capacity...
The 2021 Gilead Fellowship Research Grants Program has extended applications, meaning that...
Reductions in hospitalisations, emergency department visits and ambulance callouts have been...